Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234728 · ClinicalTrials.gov registry record · NA
Study of a New Dressing for Use With Topical Medications
A NA study, sponsored by Teikoku Pharma USA.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT00234728: Completed NA study, sponsored by Teikoku Pharma USA.
NCT00234728 is a NA study that has completed, run by Teikoku Pharma USA. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00234728, a NA study, has completed, sponsored by Teikoku Pharma USA.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a new dressing designed to be used with topical medications will enhance the effects of these topical medications.
Interventions
- DEVICE Occlusive dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-06 |
| Phase | NA |
What the finished NCT00234728 record still lists
NCT00234728 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Occlusive dressing is the first listed.
NCT00234728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00234728 about?
NCT00234728 is a clinical study titled "Study of a New Dressing for Use With Topical Medications". The purpose of this study is to determine if a new dressing designed to be used with topical medications will enhance the effects of these topical medications.
What is the current status of trial NCT00234728?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2005-09. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00234728?
The interventions under investigation include: Occlusive dressing (DEVICE).
Who is sponsoring clinical trial NCT00234728?
This trial is sponsored by Teikoku Pharma USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00234728's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia